COVID-19 Plasma Donation

Versiti is no longer accepting new COVID convalescent plasma (CCP) donors due to the rapid expansion of improved pharmaceautical therapies for treating COVID-19.

The limited FDA authorization for performing these tests on blood donors was intended for use in identifying CCP donors. This means Versiti is additionally required to discontinue screening and will no longer be performing antibody tests on blood donations starting March 26, 2021.

If you are currently scheduled to donate plasma through our program, an area coordinator will be in contact with you directly if there are changes to your existing appointment.

For questions:

see FDA.gov Investigational COVID-19 Convalescent Plasma Emergency INDs
or email us COVID19Plasma

We are enormously grateful to all of those who stepped up to help others in our communities through the last year.

Your selfless acts prove we are stronger together.

COVID-19 convalescent plasma has not been approved or licensed by FDA; COVID-19 convalescent plasma has been authorized by FDA under an EUA; COVID-19 convalescent plasma is authorized only for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.